Freemantle, N;
Piketty, C;
(2021)
Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis.
Journal of Investigational Allergology and Clinical Immunology
, 31
(6)
pp. 528-529.
10.18176/jiaci.0727.
Preview |
Text
Freemantle_Letter Final 280521.pdf - Accepted Version Download (228kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.18176/jiaci.0727 |
| Publisher version: | http://doi.org/10.18176/jiaci.0727 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Nemolizumab, Adult atopic dermatitis |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10141982 |
Downloads since deposit
114Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
